(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[(2S,3R)-3-cyclohexyl-2-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-pyrrolidine-1-carbonyl]-2-methylpropyl}-succinamic acid

ID: ALA1835320

PubChem CID: 56677089

Max Phase: Preclinical

Molecular Formula: C31H49N5O10

Molecular Weight: 651.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CC[C@H](C2CCCCC2)[C@H]1C(=O)N[C@H]1CC(=O)OC1O)C(C)C)C(C)C

Standard InChI: InChI=1S/C31H49N5O10/c1-15(2)24(32-17(5)37)28(42)33-20(13-22(38)39)27(41)35-25(16(3)4)30(44)36-12-11-19(18-9-7-6-8-10-18)26(36)29(43)34-21-14-23(40)46-31(21)45/h15-16,18-21,24-26,31,45H,6-14H2,1-5H3,(H,32,37)(H,33,42)(H,34,43)(H,35,41)(H,38,39)/t19-,20+,21+,24+,25+,26+,31?/m1/s1

Standard InChI Key: OYYYNXSICXUDAI-RTBQYLKVSA-N

Molfile:

     RDKit          2D

 46 48  0  0  0  0  0  0  0  0999 V2000
    4.0902  -21.9644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3683  -24.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6946  -24.6554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9388  -25.4443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7649  -25.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0292  -24.6755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2426  -26.1308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9172  -24.3920    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3843  -23.3546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6319  -23.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9710  -21.6980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6364  -22.1857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3070  -21.7051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0550  -20.9169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2308  -20.9163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1710  -21.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4593  -21.2855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8869  -21.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1710  -22.5230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7435  -21.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0276  -21.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7435  -22.5230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4593  -22.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0276  -22.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3159  -21.6980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0276  -20.4605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000  -21.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8842  -21.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000  -20.4605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8842  -22.5230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8842  -20.0480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1675  -20.4616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8834  -19.2241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1725  -21.2855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5434  -21.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2551  -21.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5434  -22.5230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1725  -22.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2551  -22.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2551  -20.4605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9366  -23.4548    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2517  -22.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0340  -23.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6512  -22.4832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4807  -21.6716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6985  -21.4160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 10  1  1
  2  6  1  0
  5  7  2  0
  3  8  1  0
  2  9  1  1
 10  9  1  0
 11 12  1  0
  2  3  1  0
  3  4  1  0
 16 17  1  0
 16 18  1  0
 16 19  2  0
 17 20  1  0
 20 21  1  0
 20 22  1  6
 22 23  1  0
 22 24  1  0
 21 25  1  0
 21 26  2  0
 25 27  1  0
 27 28  1  0
 27 29  1  1
 28 30  2  0
 29 31  1  0
 31 32  1  0
 31 33  2  0
 28 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  1  6
 37 38  1  0
 37 39  1  0
 36 11  1  0
 36 40  2  0
  4  5  1  0
 10 41  2  0
 13  1  1  6
  5  6  1  0
  1 42  1  0
 12 13  1  0
 42 43  1  0
 13 14  1  0
 43 44  1  0
 14 15  1  0
 44 45  1  0
 15 11  1  0
 45 46  1  0
 46  1  1  0
M  END

Associated Targets(Human)

CASP2 Tchem Caspase-2 (173 Activities)

Discover Target: CASP2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CASP3 Tchem Caspase-3 (3632 Activities)

Discover Target: CASP3

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 651.76	Molecular Weight (Monoisotopic): 651.3479	AlogP: -0.21	#Rotatable Bonds: 13
Polar Surface Area: 220.54	Molecular Species: ACID	HBA: 9	HBD: 6
#RO5 Violations: 2	HBA (Lipinski): 15	HBD (Lipinski): 6	#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.26	CX Basic pKa: ┄	CX LogP: -0.20	CX LogD: -3.19
Aromatic Rings: ┄	Heavy Atoms: 46	QED Weighted: 0.14	Np Likeness Score: 0.46

References

1. Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Muñoz-Sanjuán I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C.. (2011) Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors., 19 (19): [PMID:21903398] [10.1016/j.bmc.2011.08.020]
2. Chen, Yi-Hua YH and 9 more authors. 2006-03-09 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. [PMID:16509578]
3. Maillard, Michel C MC and 17 more authors. 2011-10-01 Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. [PMID:21903398]

(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[(2S,3R)-3-cyclohexyl-2-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-pyrrolidine-1-carbonyl]-2-methylpropyl}-succinamic acid

Names and Identifiers

Alternative Forms

Associated Targets(Human)

Molecule Features

Drug Indications

Mechanisms of Action

Biocomponents

Calculated Properties

References

Source